Pharmain Corporation

Bothell, WA 98011

SBIR Award Summary

Total Number of Awards 31
Total Value of Awards $12.1MM
First Award Date 09/30/04
Most Recent Award Date 08/10/17

Key Personnel

Last Name Name Awards Contact
Bolotin Elijah M Bolotin 18
Castillo Gerardo M Castillo 19
Reichstetter Sandra Reichstetter 5

31 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 08/10/17 - 03/31/18

ABSTRACT: This application is seeking funding specifically for Chemistry, Manufacturing, and Control (CMC) of scale-up production of long acting atrial natriuretic peptide (dANP) and its protected graft co-polymer (PGC) excipient for use in heart failure (HF) treatment. The extrinsic merit of this project will be the availability of cGMP grade P...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 07/01/15 - 06/30/16

DESCRIPTION (provided by applicant): The prevalence of all types of ascites, irrespective of the cause, is 41.7 in 100,000 with 80% of these due to cirrhosis. Ascites is treated with a salt restricted diet and pharmacologic therapy using diuretics. However, in 5% to 10% of patients with ascites, the ascites becomes refractory to medical therapy....

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-044
Budget: 02/01/15 - 01/31/16

DESCRIPTION (provided by applicant): New treatments for radiation injury to the GI-tract are desperately needed to ensure survival after exposure to ionizing radiation arising from accident, nuclear warfare, or terrorist attacks (dirty bombs). Radiation-injuries to the hematopoietic system and the GI-tract are fatal, with the latter more acutely...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 09/22/14 - 06/30/15

DESCRIPTION (provided by applicant): The prevalence of all types of ascites, irrespective of the cause, is 41.7 in 100,000 with 80% of these due to cirrhosis. Ascites is treated with a salt restricted diet and pharmacologic therapy using diuretics. However, in 5% to 10% of patients with ascites, the ascites becomes refractory to medical therapy....

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/01/14 - 08/31/15

DESCRIPTION (provided by applicant): New therapies are desperately needed to relieve patients with Type 1 diabetes from the neuropathy, nephropathy and retinopathy associated with the current standard of treatment, injected insulin. Transplantation of pancreatic islet -cells, in combination with immunosuppressant to avoid immune rejection, is re...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-088
Budget: 02/15/14 - 10/31/14

DESCRIPTION (provided by applicant): Female sexual arousal disorder (FSAD), one of the conditions commonly described as Female sexual dysfunction (FSD) is common among older women and can be a significant reason for decreased quality of life in the aging population. FSAD is defined as the persistent or recurring inability to attain or maintain s...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-044
Budget: 02/05/14 - 01/31/15

DESCRIPTION (provided by applicant): New treatments for radiation injury to the GI-tract are desperately needed to ensure survival after exposure to ionizing radiation arising from accident, nuclear warfare, or terrorist attacks (dirty bombs). Radiation-injuries to the hematopoietic system and the GI-tract are fatal, with the latter more acutely...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/15/13 - 08/31/14

DESCRIPTION (provided by applicant): New therapies are desperately needed to relieve patients with Type 1 diabetes from the neuropathy, nephropathy and retinopathy associated with the current standard of treatment, injected insulin. Transplantation of pancreatic islet -cells, in combination with immunosuppressant to avoid immune rejection, is re...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 09/01/13 - 08/31/14

DESCRIPTION (provided by applicant): Psoriasis is a chronic inflammatory skin disease that to this date is only insufficiently controlled by currently available treatments which can also come with severe, and sometimes life threatening side effects. In this application, we propose to create a new class of biologics drug for the treatment of this...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 05/01/13 - 04/30/14

DESCRIPTION (provided by applicant): Lyso, a metalloendopeptidase that is bacteriolytic for S. aureus, is a potential systemic therapy for treating methicillin-resistant S. aureus (MRSA) mediated infections including endocarditis, osteomyelitis, catheter related infections, and MRSA-mediated community acquired furunculosis and pneumonia. However...

Load More